Gene: HECW1
Official Full Name: HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1provided by HGNC
Gene Summary: Predicted to enable ubiquitin protein ligase activity. Predicted to be involved in regulation of dendrite morphogenesis and ubiquitin-dependent protein catabolic process. Predicted to be located in cytosol. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO29918 | HECW1 Knockout cell line (HeLa) | Human | HECW1 | 1:3~1:6 | Negative | Online Inquiry |
KO29919 | HECW1 Knockout cell line (HCT 116) | Human | HECW1 | 1:2~1:4 | Negative | Online Inquiry |
KO29920 | HECW1 Knockout cell line (HEK293) | Human | HECW1 | 1:3~1:6 | Negative | Online Inquiry |
KO29921 | HECW1 Knockout cell line (A549) | Human | HECW1 | 1:3~1:4 | Negative | Online Inquiry |
HECW1 Gene Knockout Cell Lines are specially engineered cellular models that have been designed to facilitate the in-depth study of the HECW1 gene, which plays a crucial role in various cellular processes, including apoptosis and cellular response mechanisms. These cell lines are created through precise gene-editing techniques, such as CRISPR/Cas9, that effectively disrupt the HECW1 gene, allowing researchers to observe the resultant phenotypic changes and molecular pathways affected by this knockout.
The primary function of HECW1 Gene Knockout Cell Lines is to provide a platform for investigating the gene's contributions to cancer biology, cellular stress responses, and developmental processes. By eliminating the expression of HECW1, researchers can study its effects on pathways such as ubiquitination and protein degradation, thus uncovering potential targets for therapeutic intervention.
The scientific importance of these cell lines cannot be overstated, as they serve as valuable tools in both academic and clinical research settings. They enable the exploration of the implications of HECW1 disruption in disease models, helping to identify biomarkers and therapeutic targets. Moreover, they can be instrumental in validating drug effects and understanding resistance mechanisms in cancer therapy.
What sets HECW1 Gene Knockout Cell Lines apart from alternatives is their unmatched specificity and reliability. The targeted gene knockout ensures that studies yield reproducible results, minimizing off-target effects that may obscure outcomes. Additionally, our consistent quality control measures ensure that these cell lines maintain their integrity over time, providing researchers with dependable resources for their work.
Researchers and clinicians will find these cell lines invaluable, as they not only expedite the process of understanding gene function and its implications in disease but also support cutting-edge research aimed at developing new therapeutic strategies. Whether it is for the investigation of fundamental biological questions or the advancement of clinical applications, HECW1 Gene Knockout Cell Lines offer significant advantages.
Our company, known for its commitment to high-quality biological products and expertise in genetic engineering, is dedicated to providing researchers with the tools they need to propel their studies forward. With a focus on innovation and scientific integrity, we strive to support advancements in the life sciences.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.